Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 25
Filter
Add more filters










Publication year range
1.
Neural Regen Res ; 20(2): 424-439, 2025 Feb 01.
Article in English | MEDLINE | ID: mdl-38819046

ABSTRACT

Alzheimer's disease is a debilitating, progressive neurodegenerative disorder characterized by the progressive accumulation of abnormal proteins, including amyloid plaques and intracellular tau tangles, primarily within the brain. Lysosomes, crucial intracellular organelles responsible for protein degradation, play a key role in maintaining cellular homeostasis. Some studies have suggested a link between the dysregulation of the lysosomal system and pathogenesis of neurodegenerative diseases, including Alzheimer's disease. Restoring the normal physiological function of lysosomes hold the potential to reduce the pathological burden and improve the symptoms of Alzheimer's disease. Currently, the efficacy of drugs in treating Alzheimer's disease is limited, with major challenges in drug delivery efficiency and targeting. Recently, nanomaterials have gained widespread use in Alzheimer's disease drug research owing to their favorable physical and chemical properties. This review aims to provide a comprehensive overview of recent advances in using nanomaterials (polymeric nanomaterials, nanoemulsions, and carbon-based nanomaterials) to enhance lysosomal function in treating Alzheimer's disease. This review also explores new concepts and potential therapeutic strategies for Alzheimer's disease through the integration of nanomaterials and modulation of lysosomal function. In conclusion, this review emphasizes the potential of nanomaterials in modulating lysosomal function to improve the pathological features of Alzheimer's disease. The application of nanotechnology to the development of Alzheimer's disease drugs brings new ideas and approaches for future treatment of this disease.

2.
Burns Trauma ; 12: tkae009, 2024.
Article in English | MEDLINE | ID: mdl-38841099

ABSTRACT

Background: Given the significant impact on human health, it is imperative to develop novel treatment approaches for diabetic wounds, which are prevalent and serious complications of diabetes. The diabetic wound microenvironment has a high level of reactive oxygen species (ROS) and an imbalance between proinflammatory and anti-inflammatory cells/factors, which hamper the healing of chronic wounds. This study aimed to develop poly(L-lactic acid) (PLLA) nanofibrous membranes incorporating curcumin and silver nanoparticles (AgNPs), defined as PLLA/C/Ag, for diabetic wound healing. Methods: PLLA/C/Ag were fabricated via an air-jet spinning approach. The membranes underwent preparation and characterization through various techniques including Fourier-transform infrared spectroscopy, measurement of water contact angle, X-ray photoelectron spectroscopy, X-ray diffraction, scanning electron microscopy, assessment of in vitro release of curcumin and Ag+, testing of mechanical strength, flexibility, water absorption and biodegradability. In addition, the antioxidant, antibacterial and anti-inflammatory properties of the membranes were evaluated in vitro, and the ability of the membranes to heal wounds was tested in vivo using diabetic mice. Results: Loose hydrophilic nanofibrous membranes with uniform fibre sizes were prepared through air-jet spinning. The membranes enabled the efficient and sustained release of curcumin. More importantly, antibacterial AgNPs were successfully reduced in situ from AgNO3. The incorporation of AgNPs endowed the membrane with superior antibacterial activity, and the bioactivities of curcumin and the AgNPs gave the membrane efficient ROS scavenging and immunomodulatory effects, which protected cells from oxidative damage and reduced inflammation. Further results from animal studies indicated that the PLLA/C/Ag membranes had the most efficient wound healing properties, which were achieved by stimulating angiogenesis and collagen deposition and inhibiting inflammation. Conclusions: In this research, we successfully fabricated PLLA/C/Ag membranes that possess properties of antioxidants, antibacterial agents and anti-inflammatory agents, which can aid in the process of wound healing. Modulating wound inflammation, these new PLLA/C/Ag membranes serve as a novel dressing to enhance the healing of diabetic wounds.

3.
Adv Sci (Weinh) ; 11(21): e2400898, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38647422

ABSTRACT

Fabrication of versatile hydrogels in a facile and effective manner represents a pivotal challenge in the field of biomaterials. Herein, a novel strategy is presented for preparing on-demand degradable hydrogels with multilevel responsiveness. By employing selenol-dichlorotetrazine nucleophilic aromatic substitution (SNAr) to synthesize hydrogels under mild conditions in a buffer solution, the necessity of additives or posttreatments can be obviated. The nucleophilic and redox reactions between selenol and tetrazine culminate in the formation of three degradable chemical bonds-diselenide, aryl selenide, and dearomatized selenide-in a single, expeditious step. The resultant hydrogel manifests exceptional adaptability to intricate environments in conjunction with self-healing and on-demand degradation properties. Furthermore, the resulting material demonstrated light-triggered antibacterial activity. Animal studies further underscore the potential of integrating metformin into Se-Tz hydrogels under green light irradiation, as it effectively stimulates angiogenesis and collagen deposition, thereby fostering efficient wound healing. In comparison to previously documented hydrogels, Se-Tz hydrogels exhibit controlled degradation and drug release, outstanding antibacterial activity, mechanical robustness, and bioactivity, all without the need for costly and intricate preparation procedures. These findings underscore Se-Tz hydrogels as a safe and effective therapeutic option for diabetic wound dressings.


Subject(s)
Anti-Bacterial Agents , Hydrogels , Wound Healing , Wound Healing/drug effects , Hydrogels/chemistry , Animals , Mice , Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/chemistry , Biocompatible Materials/chemistry , Biocompatible Materials/pharmacology , Disease Models, Animal
4.
Adv Healthc Mater ; : e2304060, 2024 Mar 01.
Article in English | MEDLINE | ID: mdl-38429938

ABSTRACT

Surgical resection of bone tumors is the primary approach employed in the treatment of bone cancer. Simultaneously, perioperative interventions, particularly postoperative adjuvant anticancer strategies, play a crucial role in achieving satisfactory therapeutic outcomes. However, the occurrence of postoperative bone tumor recurrence, metastasis, extensive bone defects, and infection are significant risks that can result in unfavorable prognoses or even treatment failure. In recent years, there has been significant progress in the development of biomaterials, leading to the emergence of new treatment options for bone tumor therapy and bone regeneration. This progress report aims to comprehensively analyze the strategic development of unique therapeutic biomaterials with inherent healing properties and bioactive capabilities for bone tissue regeneration. These composite biomaterials, classified into metallic, inorganic non-metallic, and organic types, are thoroughly investigated for their responses to external stimuli such as light or magnetic fields, internal interventions including chemotherapy or catalytic therapy, and combination therapy, as well as their role in bone regeneration. Additionally, an overview of self-healing materials for osteogenesis is provided and their potential applications in combating osteosarcoma and promoting bone formation are explored. Furthermore, the safety concerns of integrated materials and current limitations are addressed, while also discussing the challenges and future prospects.

5.
Int J Nanomedicine ; 19: 327-345, 2024.
Article in English | MEDLINE | ID: mdl-38229707

ABSTRACT

Ischemic stroke, a condition that often leads to severe nerve damage, induces complex pathological and physiological changes in nerve tissue. The mature central nervous system (CNS) lacks intrinsic regenerative capacity, resulting in a poor prognosis and long-term neurological impairments. There is no available therapy that can fully restore CNS functionality. However, the utilization of injectable hydrogels has emerged as a promising strategy for nerve repair and regeneration. Injectable hydrogels possess exceptional properties, such as biocompatibility, tunable mechanical properties, and the ability to provide a supportive environment for cell growth and tissue regeneration. Recently, various hydrogel-based tissue engineering approaches, including cell encapsulation, controlled release of therapeutic factors, and incorporation of bioactive molecules, have demonstrated great potential in the treatment of CNS injuries caused by ischemic stroke. This article aims to provide a comprehensive review of the application and development of injectable hydrogels for the treatment of ischemic stroke-induced CNS injuries, shedding light on their therapeutic prospects, challenges, recent advancements, and future directions. Additionally, it will discuss the underlying mechanisms involved in hydrogel-mediated nerve repair and regeneration, as well as the need for further preclinical and clinical studies to validate their efficacy and safety.


Subject(s)
Ischemic Stroke , Plastic Surgery Procedures , Humans , Hydrogels/pharmacology , Ischemic Stroke/therapy , Tissue Engineering/methods , Central Nervous System , Nerve Regeneration
6.
J Control Release ; 366: 85-103, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38142964

ABSTRACT

Recently, biomembrane nanostructures, such as liposomes, cell membrane-coated nanostructures, and exosomes, have demonstrated promising anticancer therapeutic effects. These nanostructures possess remarkable biocompatibility, multifunctionality, and low toxicity. However, their therapeutic efficacy is impeded by chemoresistance and radiotherapy resistance, which are closely associated with autophagy. Modulating autophagy could enhance the therapeutic sensitivity and effectiveness of these biomembrane nanostructures by influencing the immune system and the cancer microenvironment. For instance, autophagy can regulate the immunogenic cell death of cancer cells, antigen presentation of dendritic cells, and macrophage polarization, thereby activating the inflammatory response in the cancer microenvironment. Furthermore, combining autophagy-regulating drugs or genes with biomembrane nanostructures can exploit the targeting and long-term circulation properties of these nanostructures, leading to increased drug accumulation in cancer cells. This review explores the role of autophagy in carcinogenesis, cancer progression, metastasis, cancer immune responses, and resistance to treatment. Additionally, it highlights recent research advancements in the synergistic anticancer effects achieved through autophagy regulation by biomembrane nanostructures. The review also discusses the prospects and challenges associated with the future clinical translation of these innovative treatment strategies. In summary, these findings provide valuable insights into autophagy, autophagy-modulating biomembrane-based nanostructures, and the underlying molecular mechanisms, thereby facilitating the development of promising cancer therapeutics.


Subject(s)
Nanostructures , Neoplasms , Humans , Neoplasms/drug therapy , Antigen Presentation , Autophagy , Cell Membrane , Tumor Microenvironment
7.
Int J Nanomedicine ; 18: 7441-7468, 2023.
Article in English | MEDLINE | ID: mdl-38090364

ABSTRACT

Current therapies for Alzheimer's disease used in the clinic predominantly focus on reducing symptoms with limited capability to control disease progression; thus, novel drugs are urgently needed. While nanoparticles (liposomes, high-density lipoprotein-based nanoparticles) constructed with synthetic biomembranes have shown great potential in AD therapy due to their excellent biocompatibility, multifunctionality and ability to penetrate the BBB, nanoparticles derived from natural biomembranes (extracellular vesicles, cell membrane-based nanoparticles) display inherent biocompatibility, stability, homing ability and ability to penetrate the BBB, which may present a safer and more effective treatment for AD. In this paper, we reviewed the synthetic and natural biomembrane-derived nanoparticles that are used in AD therapy. The challenges associated with the clinical translation of biomembrane-derived nanoparticles and future perspectives are also discussed.


Subject(s)
Alzheimer Disease , Nanoparticles , Humans , Alzheimer Disease/drug therapy , Liposomes/pharmacology , Blood-Brain Barrier
8.
Mater Today Bio ; 23: 100810, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37810755

ABSTRACT

Diabetic wounds (DWs) pose a major challenge for the public health system owing to their high incidence, complex pathogenesis, and long recovery time; thus, there is an urgent need to develop innovative therapies to accelerate the healing process of diabetic wounds. As natural nanovesicles, extracellular vesicles (EVs) are rich in sources with low immunogenicity and abundant nutritive molecules and exert potent therapeutic effects on diabetic wound healing. To avoid the rapid removal of EVs, a suitable delivery system is required for their controlled release. Owing to the advantages of high porosity, good biocompatibility, and adjustable physical and chemical properties of hydrogels, EV biopotentiated hydrogels can aid in achieving precise and favorable therapy against diabetic wounds. This review highlights the different design strategies, therapeutic effects, and mechanisms of EV biopotentiated hydrogels. We also discussed the future challenges and opportunities of using EV biopotentiated hydrogels for diabetic wound healing.

9.
Int J Nanomedicine ; 18: 5243-5264, 2023.
Article in English | MEDLINE | ID: mdl-37727650

ABSTRACT

Cancer is the second leading cause of death worldwide. Its incidence has been increasing in recent years, and it is becoming a major threat to human health. Conventional cancer treatment strategies, including surgery, chemotherapy, and radiotherapy, have faced problems such as drug resistance, toxic side effects and unsatisfactory therapeutic efficacy. Therefore, better development and utilization of biomaterials can improve the specificity and efficacy of tumor therapy. Algae, as a novel living material, possesses good biocompatibility. Although some reviews have elucidated several algae-based biomaterials for cancer treatment, the majority of the literature has focused on a limited number of algae. As a result, there is currently a lack of comprehensive reviews on the subject of anticancer algae. This review aims to address this gap by conducting a thorough examination of algal species that show potential for anticancer activity. Furthermore, our review will also elucidate the engineering strategies of algae and discuss the challenges and prospects associated with their implementation.


Subject(s)
Drug-Related Side Effects and Adverse Reactions , Neoplasms , Humans , Neoplasms/drug therapy , Biocompatible Materials
10.
J Control Release ; 361: 102-114, 2023 09.
Article in English | MEDLINE | ID: mdl-37532150

ABSTRACT

Percutaneous microwave ablation (PMA) is a thermoablative method used as a minimally invasive treatment for liver cancer. However, the application of PMA is limited by its insufficient ROS generation efficiency and thermal effects. Herein, a new microwave-activated Cu-doped zirconium metal-organic framework (MOF) (CuZr MOF) used for enhanced PMA has a significantly improved microwave sensitizing effect. Owing to the strong inelastic collisions between ions confined in numerous micropores, CuZr MOF has strong microwave sensitivity and high thermal conversion efficiency, which can significantly improve microwave thermal therapy (MTT). Moreover, because of the existence of Cu2+ ions, a further benefit of CuZr MOF is their Fenton-like activity, in particular, microwaves used as an excitation source for microwave dynamic therapy (MDT) can improve the Fenton-like reaction to maximize the synergistic effectiveness of cancer therapy. Importantly, CuZr MOF can inhibit the production of heat shock proteins (HSPs) by producing abundant ROS to enhance tumor destruction. Mechanistically, we found that CuZr MOF + MW treatment modulates ferroptosis-mediated tumor cell death by targeting the HMOX1/GPX4 axis. In summary, this study develops a novel CuZr MOF microwave sensitizer with great potential for synergistic treatment of liver cancer by MTT and MDT.


Subject(s)
Liver Neoplasms , Metal-Organic Frameworks , Humans , Microwaves , Zirconium , Reactive Oxygen Species/metabolism
11.
J Control Release ; 361: 510-533, 2023 09.
Article in English | MEDLINE | ID: mdl-37567505

ABSTRACT

Chemotherapeutic drugs have been found to activate the immune response against tumors by inducing immunogenic cell death, in addition to their direct cytotoxic effects toward tumors, therefore broadening the application of chemotherapy in tumor immunotherapy. The combination of other therapeutic strategies, such as phototherapy or radiotherapy, could further strengthen the therapeutic effects of immunotherapy. Nanostructures can facilitate multimodal tumor therapy by integrating various active agents and combining multiple types of therapeutics in a single nanostructure. Biomembrane nanostructures (e.g., exosomes and cell membrane-derived nanostructures), characterized by superior biocompatibility, intrinsic targeting ability, intelligent responsiveness and immune-modulating properties, could realize superior chemoimmunotherapy and represent next-generation nanostructures for tumor immunotherapy. This review summarizes recent advances in biomembrane nanostructures in tumor chemoimmunotherapy and highlights different types of engineering approaches and therapeutic mechanisms. A series of engineering strategies for combining different biomembrane nanostructures, including liposomes, exosomes, cell membranes and bacterial membranes, are summarized. The combination strategy can greatly enhance the targeting, intelligence and functionality of biomembrane nanostructures for chemoimmunotherapy, thereby serving as a stronger tumor therapeutic method. The challenges associated with the clinical translation of biomembrane nanostructures for chemoimmunotherapy and their future perspectives are also discussed.


Subject(s)
Antineoplastic Agents , Nanostructures , Neoplasms , Humans , Drug Delivery Systems , Neoplasms/drug therapy , Neoplasms/pathology , Antineoplastic Agents/therapeutic use , Antineoplastic Agents/pharmacology , Immunotherapy , Nanostructures/chemistry , Tumor Microenvironment
12.
Front Hum Neurosci ; 17: 1187794, 2023.
Article in English | MEDLINE | ID: mdl-37275341

ABSTRACT

There are increasing epilepsy patients suffering from the pain of seizure onsets, and effective prediction of seizures could improve their quality of life. To obtain high sensitivity for epileptic seizure prediction, current studies generally need complex feature extraction operations, which heavily depends on the artificial experience (or domain knowledge) and is highly subjective. To address these issues, in this paper we propose an end-to-end epileptic seizure prediction approach based on the long short-term memory network (LSTM). In the new method, only the gamma band of raw electroencephalography (EEG) signals is extracted as network input directly for seizure prediction, thus avoiding subjective and expensive feature design process. Despite its simplicity, the proposed method achieves the mean sensitivity of 91.76% and false prediction rate (FPR) of 0.29/h on Children's Hospital Boston-MIT (CHB-MIT) scalp EEG Database, respectively, when identifying the preictal stage from the EEG signals. Furthermore, different from traditional methods that only consider the classification of preictal and interictal EEG, we introduce the postictal stage as an extra class in the proposed method. As a result, the performance of seizure prediction is further improved, obtaining a higher sensitivity of 92.17% and a low FPR of 0.27/h. The mean warning time is 44.46 min, which suggests that sufficient time is reserved for patients to take intervention measures by this prediction method.

13.
Biomater Res ; 27(1): 49, 2023 May 18.
Article in English | MEDLINE | ID: mdl-37202774

ABSTRACT

BACKGROUND: Multifunctional hydrogels with controllable degradation and drug release have attracted extensive attention in diabetic wound healing. This study focused on the acceleration of diabetic wound healing with selenide-linked polydopamine-reinforced hybrid hydrogels with on-demand degradation and light-triggered nanozyme release. METHODS: Herein, selenium-containing hybrid hydrogels, defined as DSeP@PB, were fabricated via the reinforcement of selenol-end capping polyethylene glycol (PEG) hydrogels by polydopamine nanoparticles (PDANPs) and Prussian blue nanozymes in a one-pot approach in the absence of any other chemical additive or organic solvent based on diselenide and selenide bonding-guided crosslinking, making them accessible for large-scale mass production. RESULTS: Reinforcement by PDANPs greatly increases the mechanical properties of the hydrogels, realizing excellent injectability and flexible mechanical properties for DSeP@PB. Dynamic diselenide introduction endowed the hydrogels with on-demand degradation under reducing or oxidizing conditions and light-triggered nanozyme release. The bioactivity of Prussian blue nanozymes afforded the hydrogels with efficient antibacterial, ROS-scavenging and immunomodulatory effects, which protected cells from oxidative damage and reduced inflammation. Further animal studies indicated that DSeP@PB under red light irradiation showed the most efficient wound healing activity by stimulating angiogenesis and collagen deposition and inhibiting inflammation. CONCLUSION: The combined merits of DSeP@PB (on-demand degradation, light-triggered release, flexible mechanical robustness, antibacterial, ROS-scavenging and immunomodulatory capacities) enable its high potential as a new hydrogel dressing that can be harnessed for safe and efficient therapeutics for diabetic wound healing.

14.
Int J Nanomedicine ; 18: 2413-2429, 2023.
Article in English | MEDLINE | ID: mdl-37192898

ABSTRACT

Helicobacter pylori (H. pylori) is an infectious pathogen and the leading cause of gastrointestinal diseases, including gastric adenocarcinoma. Currently, bismuth quadruple therapy is the recommended first-line treatment, and it is reported to be highly effective, with >90% eradication rates on a consistent basis. However, the overuse of antibiotics causes H. pylori to become increasingly resistant to antibiotics, making its eradication unlikely in the foreseeable future. Besides, the effect of antibiotic treatments on the gut microbiota also needs to be considered. Therefore, effective, selective, antibiotic-free antibacterial strategies are urgently required. Due to their unique physiochemical properties, such as the release of metal ions, the generation of reactive oxygen species, and photothermal/photodynamic effects, metal-based nanoparticles have attracted a great deal of interest. In this article, we review recent advances in the design, antimicrobial mechanisms and applications of metal-based nanoparticles for the eradication of H. pylori. Additionally, we discuss current challenges in this field and future perspectives that may be used in anti-H. pylori strategies.


Subject(s)
Helicobacter Infections , Helicobacter pylori , Nanoparticles , Humans , Helicobacter Infections/drug therapy , Proton Pump Inhibitors/pharmacology , Proton Pump Inhibitors/therapeutic use , Drug Therapy, Combination , Anti-Bacterial Agents/pharmacology , Bismuth/pharmacology
15.
Adv Healthc Mater ; 12(17): e2300315, 2023 07.
Article in English | MEDLINE | ID: mdl-36848378

ABSTRACT

Osteoarthritis is a degenerative disorder that can severely affect joints, and new treatment strategies are urgently needed. Administration of mesenchymal stem cell (MSC)-derived exosomes is a promising therapeutic strategy in osteoarthritis treatment. However, the poor yield of exosomes is an obstacle to the use of this modality in the clinic. Herein, a promising strategy is developed to fabricate high-yield exosome-mimicking MSC-derived nanovesicles (MSC-NVs) with enhanced regenerative and anti-inflammatory capabilities. MSC-NVs are prepared using an extrusion approach and are found to increase chondrocyte and human bone marrow MSC differentiation, proliferation, and migration, in addition to inducing M2 macrophage polarization. Furthermore, gelatin methacryloyl (GelMA) hydrogels loaded with MSC-NVs (GelMA-NVs) are formulated, which exhibit sustained release of MSC-NVs and are shown to be biocompatible with excellent mechanical properties. In a mouse osteoarthritis model constructed by surgical destabilization of the medial meniscus (DMM), GelMA-NVs effectively ameliorate osteoarthritis severity, reduce the secretion of catabolic factors, and enhance matrix synthesis. Furthermore, GelMA-NVs induce M2 macrophage polarization and inflammatory response inhibition in vivo. The findings demonstrate that GelMA-NVs hold promise for osteoarthritis treatment through modulation of chondrogenesis and macrophage polarization.


Subject(s)
Mesenchymal Stem Cells , Osteoarthritis , Mice , Animals , Humans , Hydrogels/pharmacology , Hydrogels/metabolism , Chondrogenesis , Osteoarthritis/therapy , Gelatin/pharmacology , Disease Models, Animal , Macrophages
16.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-986244

ABSTRACT

@#[摘 要] 目的:构建负载二氧化锰(MnO2)纳米颗粒的可得然(Cur)复合水凝胶MnO2@Cur(简称MGel),研究其对黑色素瘤B16-F10细胞的杀伤效果。方法:采用热诱导法制备Cur水凝胶(Gel),物理负载MnO2构建MGel,表征其宏观和微观形貌,检测其机械性能、降解性能以及光热转换性能等理化性能,并研究其联合PTT对小鼠皮肤黑色素瘤B16-F10细胞的光热杀伤效果。结果:MGel具有优异的机械和可降解性能,抗拉伸强度达(127.97±3.60)kPa、抗压缩强度达(151.44±5.23)kPa,28 d降解率约58.17%。MGel负载MnO2纳米片(粒径约180 nm)获得优异的光热转换性能,负载1.0 mg/mL MnO2的MGel在1.0 W/cm2的808 nm NIR光照4 min后到达最高温度50 ℃。细胞毒性实验和Calcein-AM/PI荧光双染色实验表明,MGel联合PTT有效杀伤B16-F10黑色素瘤细胞,NIR光照使得MGel组细胞存活率降低至(4.68±0.66)%(P<0.000 1)。结论:MGel复合水凝胶具备优异的机械性能、可降解性能以及光热转换性能,其联合PTT能有效杀伤肿瘤细胞,可能成为一种有效治疗黑色素瘤的新手段。

17.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-977721

ABSTRACT

@#[摘 要] 目的:构建中空硫化铜纳米酶脂质复合载体CuS@LIP并探讨其联合激光照射杀伤黑色素瘤B6-F10细胞的效果与机制。方法:构建(2,3-二油酰基-丙基)-三甲胺-丙烷(氯盐)(DOTAP)阳离子脂质体包被硫化铜纳米载体CuS@LIP,研究不同质量浓度的CuS与CuS@LIP在1 064 nm激光照射下的光热性能和热稳定性,通过H2O2与3,3',5,5'-四甲基联苯胺(TMB)催化活性检测体系检测CuS@LIP的类过氧化物活性;用系列质量浓度梯度的CuS、CuS@LIP在有/无激光条件下分别处理B16-F10细胞,CCK-8法检测细胞的存活率,Calcein-AM/PI染色法、Annexin Ⅴ-FITC/PI染色法结合流式细胞仪分别检测20 μg/mL CuS或CuS@LIP在激光照射或非激光照射条件下对B16-F10细胞活力和凋亡的影响。结果:成功制备的CuS@LIP的平均粒径为(178.23±6.46)nm,平均Zeta电位为(20.47±0.93)mV;在激光照射下,80 μg/mL CuS@LIP最高温度可达65.4 ℃,比单纯CuS的63.4 ℃更高;经3个激光开关周期测试,CuS@LIP终点温度基本保持不变;此外,CuS@LIP与CuS具有相同的类过氧化物酶催化活性。低于20 μg/mL的CuS@LIP在体外对B16-F10细胞的增殖活性没有明显影响(P>0.05),但联合激光照射后细胞存活率明显降低(29.76±3.60)% vs (87.95±8.18)%,P<0.000 1,细胞凋亡率显著升高[(19.34±4.41)% vs (13.36±0.86)%,P<0.01]。结论:制备的CuS@LIP具有符合设计要求的理化性质、良好的光热性能和优异的类过氧化物酶催化活性,其与激光照射联合后显示出更优异的杀伤B16-F10细胞的效果。

18.
Front Neurosci ; 16: 982541, 2022.
Article in English | MEDLINE | ID: mdl-36225738

ABSTRACT

As one of the most common neurological disorders, epilepsy causes great physical and psychological damage to the patients. The long-term recurrent and unprovoked seizures make the prediction necessary. In this paper, a novel approach for epileptic seizure prediction based on successive variational mode decomposition (SVMD) and transformers is proposed. SVMD is extended to multidimensional form for time-frequency analysis of multi-channel signals. It could adaptively extract common band-limited intrinsic modes among all channels on different time scales by solving a variational optimization problem. In the proposed seizure prediction method, data are first decomposed into multiple modes on different time scales by multivariate SVMD, and then, irrelevant modes are removed for preprocessing. Finally, power spectrum of denoised data is input to a pre-trained bidirectional encoder representations from transformers (BERTs) for prediction. The BERT could identify the mode information related to epileptic seizures in time-frequency domain. It shows fair prediction performance on an intracranial EEG dataset with the average sensitivity of 0.86 and FPR of 0.18/h.

19.
Nanoscale ; 12(31): 16474-16488, 2020 Aug 21.
Article in English | MEDLINE | ID: mdl-32743625

ABSTRACT

The immunomodulatory capability of biomaterials is of paramount importance for successful material-mediated bone regeneration. Particularly, the design of surface nano-topography can be leveraged to instruct immune reactions, yet the understanding of such "nano-morphology effect" is still very limited. Herein, highly ordered nano-concave pit (denoted as NCPit) and nano-convex dot (denoted as NCDot) microarrays with two different sizes were successfully constructed on a 316LSS surface via anodization and subsequently immersion-coating treatment, respectively. We, for the first time, comparatively investigated the interactions of NCPit and NCDot microarrays with RAW264.7 macrophages and their immunomodulatory impacts on osteogenesis and angiogenesis of human bone mesenchymal stem cells (hBMSCs) and human umbilical vein endothelial cells (HUVECs). NCDot microarrays induced macrophages towards M2 polarization with the higher expression level of anti-inflammatory markers (IL-10 and CD 206) and the lower level of pro-inflammatory markers (TNF-α, IL-1ß, IL-6 and CD 86) than those of the corresponding NCPit microarrays. During the process, the expressions of osteogenesis-related genes (Runx2, OPN and OCN) of hBMSCs, and angiogenesis-related genes (eNOS, HIF-1α, KDR and VEGF) of HUVECs were significantly upregulated by the NCDot microarray-modulating immune microenvironment of macrophages, and finally stimulated osteogenesis and angiogenesis. Thus, the prepared NCDot arrays were able to significantly promote osteo-/angiogenic activity by generating a more suitable immune microenvironment than NCPit arrays, offering substantial evidence for designing immunomodulatory biomaterials with specific microstructures and optimal bioactivity.


Subject(s)
Coated Materials, Biocompatible/chemistry , Immunomodulation , Neovascularization, Physiologic/immunology , Osteogenesis/immunology , Animals , Cell Differentiation , Cells, Cultured , Human Umbilical Vein Endothelial Cells/cytology , Humans , Macrophages/cytology , Macrophages/immunology , Mesenchymal Stem Cells/cytology , Mice , RAW 264.7 Cells , Surface Properties
20.
Physiol Meas ; 37(12): 2299-2316, 2016 12.
Article in English | MEDLINE | ID: mdl-27897151

ABSTRACT

The difference of brain functional connectivity between hypoxic and normal states was studied. The impact of intermittent hypoxic training on the hypoxia tolerance of the brain was explored. Multivariable empirical mode decomposition was applied to extract common inherent modes of multichannel EEG adaptively instead of a priori selection of filter bandwidth, and the first two scales of intrinsic mode functions expressed the differences in brain connectivity. To quantify synchronization and search for consistent performance, coherence, phase locking value and synchronization likelihood were all utilized. Brain networks extracted from these synchronization measures all displayed that both local and global functional connectivity declined with increasing time in a hypoxic state. Furthermore, early hypoxia of the brain was represented on brain connectivity before mental fatigue was detected by conventional neurobehavioral evaluation. The decrease of connectivity tended to slow down in hypoxic conditions after training, which indicated that hypoxia tolerance strengthened because of the hypoxic training.


Subject(s)
Brain/physiopathology , Hypoxia/physiopathology , Nerve Net/physiopathology , Adult , Electroencephalography , Humans , Male , Models, Neurological , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...